Form 4 for TWST Twist Bioscience Corp
Accepted 2026-06-26 16:41:55 ET · period of report 2026-06-25 · accession 0001214659-26-007800 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-26 16:41 | 2026-06-25 | TWST | Leproust Emily M. | CEO, Dir | S - Sale | $95.00 | -18.9K | 824.0K | -2% | -$1.79M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-25 | S | D | 18,880 | $95.00 | 824,039 | D | — | — | (F1) The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. |